Citadel Advisors - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 30 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$296,000
+116.1%
145,912
+51.8%
0.00%
Q1 2022$137,000
-41.2%
96,093
-32.9%
0.00%
Q4 2021$233,000
-64.2%
143,299
-29.8%
0.00%
Q3 2021$650,000
-37.7%
204,083
-3.3%
0.00%
Q2 2021$1,043,000
+799.1%
211,146
+1399.9%
0.00%
Q1 2021$116,00014,0770.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 181,169$259,0000.01%
CarsonAllaria Wealth Management, Ltd. 2,350$3,0000.00%
Engineers Gate Manager LP 15,428$22,0000.00%
Virtu Financial LLC 13,555$19,0000.00%
OSAIC HOLDINGS, INC. 1,602$3,0000.00%
FMR LLC 14$00.00%
US BANCORP \DE\ 2,000$3,0000.00%
WELLS FARGO & COMPANY/MN 1,682$2,0000.00%
NORTHERN TRUST CORP 42,000$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders